| Bioactivity | Sofinicline benzenesulfonate (ABT 894 benzenesulfonate) is a novel nicotinic acetylcholine receptor agonist, specifically acting on the α4β2 subtype of nAChR (IC50=0.1 nM). Sofinicline benzenesulfonate has the potential to improve cognitive function, including attention, memory and working memory. Sofinicline benzenesulfonate can be used in studies of attention deficit, hyperactivity disorder (ADHD)[1]. |
| CAS | 876170-44-4 |
| Formula | C16H17Cl2N3O3S |
| Molar Mass | 402.30 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Fleisher C, et al. Sofinicline: a novel nicotinic acetylcholine receptor agonist in the treatment of attention-deficit/hyperactivity disorder[J]. Expert opinion on investigational drugs, 2014, 23(8): 1157-1163. |
Sofinicline benzenesulfonate
CAS: 876170-44-4 F: C16H17Cl2N3O3S W: 402.30
Sofinicline benzenesulfonate (ABT 894 benzenesulfonate) is a novel nicotinic acetylcholine receptor agonist, specificall
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.